InvestorsHub Logo
Followers 89
Posts 17484
Boards Moderated 0
Alias Born 09/06/2006

Re: Doktornolittle post# 127255

Monday, 07/24/2017 5:50:19 PM

Monday, July 24, 2017 5:50:19 PM

Post# of 705558

Freezing the fkng tumor should be pretty standard at this point anyway, at least short term. DCVax-L is by no means the only experimental therapy that benefits from having the tumor to study. There are scores of therapies in development and I am sure many can benefit from having the tumor frozen.


Even if they do not need the tumor to produce the vaccine, they often need it to know if the patient is a candidate.

Some examples talked about here on this board:

Duke's DC vaccine that looks for CVM in the tunor
Duke's polio vaccine that looks for some antigen I know not
The CarT EGFRvIII targeting Ts talked about on a few TV shows.
CLDX
IMUC

And how many others we have not talked about here

Even if the docs are not up to speed on all the experimental agents, they certainly have the concept that the tumor might be useful.

And they will not be checking on insurance reimbursements in this case.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News